Search results
Added:
9 months ago
Source:
Radcliffe Cardiology
Two phase 3 trials presented at the European Society of Cardiology Congress 2025 have provided new insights into the role of myosin inhibitors for hypertrophic cardiomyopathy (HCM), with one trial demonstrating superiority over standard care in obstructive HCM and another failing to meet its primary endpoints in the non-obstructive form of the disease.¹˒²The MAPLE-HCM trial found that the cardiac…
View more
Perry Elliott
Research Area(s) / Expertise:
Job title: Director of UCL Institute of Cardiovascular Science and Professor of Cardiovascular Medicine
Author
Kenneth Ellenbogen
Research Area(s) / Expertise:
Job title: Professor and Chair, Division of Cardiology
Author
Eugene Braunwald
Research Area(s) / Expertise:
Job title: Distinguished Hersey Professor of Medicine, MACC
Author
Added:
7 months ago
Source:
Radcliffe Cardiology
New analyses from the ATTRibute-CM trial show that the transthyretin (TTR) stabiliser acoramidis provides consistent clinical benefits in patients with both wild-type (ATTRwt-CM) and variant (ATTRv-CM) transthyretin amyloid cardiomyopathy.1 The findings include data from the main 30-month trial and its ongoing 42-month open-label extension (OLE).Acoramidis is an orally administered, small…
View more
View from the Thoraxcenter: What's Hot at AHA 24?
Added:
1 year ago
Podcast Episode
Pathophysiology, Mechanism, Diagnosis and Management of PAH
Author(s):
Apoorva Gangavelli
,
Ronaldo C Fabiano
,
Mariam Riad
,
et al
Added:
5 months ago
Review Article
Overview of Genetic Risk Factors and Aetiologies
Author(s):
Sarah Ming Li Tan
,
Shir Lynn Lim
,
Marcus EH Ong
,
et al
Added:
10 months ago
Review Article
Added:
5 months ago
Source:
Radcliffe Cardiology
A novel cardiac myosin agonist, danicamtiv, has shown favourable safety and efficacy signals in patients with dilated cardiomyopathy (DCM), particularly in those with specific genetic variants, according to results from a phase 2a open-label trial.¹ Precision therapies for DCM are currently lacking, despite its diverse clinical manifestations often linked to underlying genetic causes.²Danicamtiv…
View more
Takotsubo Syndrome in a Southeast Asian Population
Author(s):
Samuel Soh Heng
,
Ignasius Jappar
,
Zee Pin Ding
Added:
1 year ago
Original Research